Rolex Rings Board of Directors

Get the latest insights into the leadership at Rolex Rings. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Manesh Dayashankar Madeka Chairman & Managing Director
Mr. Bhautik Dayashankar Madeka Whole Time Director
Mr. Mihir Rupeshkumar Madeka Whole Time Director
Mr. Pravinchandra Ratilal Dholakia Independent Director
Ms. Jignasa Pravinchandra Mehta Independent Woman Director
Mr. Ashit Ravishankar Vankani Independent Director

Rolex Rings Share price

ROLEXRINGS

1390.1

9.20 (-0.66%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:44 IST
BUYSELL
Today's High

1449.30

Today's Low

1385.00

52 Week Low

1210.40

52 Week High

2794.00

The current prices are delayed, login to your account for live prices

Rolex Rings FAQs

The board at Rolex Rings consists of experienced professionals, including Mr. Manesh Dayashankar Madeka , Mr. Bhautik Dayashankar Madeka , and others, overseeing the company’s strategic and corporate governance.

Directors at Rolex Rings are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Manesh Dayashankar Madeka is the current chairman at Rolex Rings.

Executive directors at Rolex Rings are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Rolex Rings adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Rolex Rings, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.